Annual FCF
$4.80 M
-$219.95 M-97.87%
31 December 2023
Summary:
Fulgent Genetics annual free cash flow is currently $4.80 million, with the most recent change of -$219.95 million (-97.87%) on 31 December 2023. During the last 3 years, it has fallen by -$100.70 million (-95.45%). FLGT annual FCF is now -99.07% below its all-time high of $514.73 million, reached on 31 December 2021.FLGT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$35.05 M
-$26.39 M-304.73%
30 September 2024
Summary:
Fulgent Genetics quarterly free cash flow is currently -$35.05 million, with the most recent change of -$26.39 million (-304.73%) on 30 September 2024. Over the past year, it has dropped by -$40.36 million (-759.13%). FLGT quarterly FCF is now -115.81% below its all-time high of $221.69 million, reached on 31 March 2021.FLGT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$28.67 M
-$40.36 M-345.13%
30 September 2024
Summary:
Fulgent Genetics TTM free cash flow is currently -$28.67 million, with the most recent change of -$40.36 million (-345.13%) on 30 September 2024. Over the past year, it has dropped by -$40.12 million (-350.29%). FLGT TTM FCF is now -105.17% below its all-time high of $554.12 million, reached on 30 September 2021.FLGT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLGT Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -97.9% | -759.1% | -350.3% |
| 3 y3 years | -95.5% | -123.5% | -105.2% |
| 5 y5 years | +236.8% | -1018.6% | -615.0% |
FLGT Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.1% | at low | -119.2% | at low | -105.2% | at low |
| 5 y | 5 years | -99.1% | +236.8% | -115.8% | at low | -105.2% | at low |
| alltime | all time | -99.1% | +193.5% | -115.8% | at low | -105.2% | at low |
Fulgent Genetics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$35.05 M(+304.7%) | -$28.67 M(-345.1%) |
| June 2024 | - | -$8.66 M(-369.8%) | $11.70 M(-34.8%) |
| Mar 2024 | - | $3.21 M(-72.9%) | $17.95 M(+274.2%) |
| Dec 2023 | $4.80 M(-97.9%) | $11.83 M(+122.4%) | $4.80 M(-58.1%) |
| Sept 2023 | - | $5.32 M(-320.9%) | $11.45 M(-46.7%) |
| June 2023 | - | -$2.41 M(-75.8%) | $21.48 M(-32.4%) |
| Mar 2023 | - | -$9.94 M(-153.8%) | $31.75 M(-85.9%) |
| Dec 2022 | $224.75 M(-56.3%) | $18.48 M(+20.5%) | $224.75 M(-19.0%) |
| Sept 2022 | - | $15.34 M(+95.0%) | $277.33 M(-32.5%) |
| June 2022 | - | $7.87 M(-95.7%) | $410.79 M(-13.7%) |
| Mar 2022 | - | $183.05 M(+157.6%) | $476.10 M(-7.5%) |
| Dec 2021 | $514.73 M(+387.9%) | $71.07 M(-52.2%) | $514.73 M(-7.1%) |
| Sept 2021 | - | $148.80 M(+103.3%) | $554.12 M(+37.0%) |
| June 2021 | - | $73.18 M(-67.0%) | $404.61 M(+23.9%) |
| Mar 2021 | - | $221.69 M(+100.7%) | $326.62 M(+209.6%) |
| Dec 2020 | $105.50 M | $110.46 M(<-9900.0%) | $105.50 M(-2004.0%) |
| Sept 2020 | - | -$714.00 K(-85.2%) | -$5.54 M(+447.5%) |
| June 2020 | - | -$4.82 M(-945.6%) | -$1.01 M(-125.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $570.00 K(-198.8%) | $3.98 M(-8.1%) |
| Dec 2019 | $4.33 M(-223.6%) | -$577.00 K(-115.1%) | $4.33 M(-22.1%) |
| Sept 2019 | - | $3.81 M(+2067.6%) | $5.57 M(+827.8%) |
| June 2019 | - | $176.00 K(-80.9%) | $600.00 K(-435.2%) |
| Mar 2019 | - | $921.00 K(+40.6%) | -$179.00 K(-94.9%) |
| Dec 2018 | -$3.51 M(-12.9%) | $655.00 K(-156.9%) | -$3.51 M(-46.4%) |
| Sept 2018 | - | -$1.15 M(+91.0%) | -$6.54 M(-13.8%) |
| June 2018 | - | -$603.00 K(-74.9%) | -$7.59 M(-3.3%) |
| Mar 2018 | - | -$2.41 M(+1.0%) | -$7.85 M(+95.0%) |
| Dec 2017 | -$4.03 M(-752.4%) | -$2.38 M(+8.4%) | -$4.03 M(+404.4%) |
| Sept 2017 | - | -$2.20 M(+154.7%) | -$798.00 K(+29.1%) |
| June 2017 | - | -$863.00 K(-160.9%) | -$618.00 K(-146.2%) |
| Mar 2017 | - | $1.42 M(+67.8%) | $1.34 M(+116.7%) |
| Dec 2016 | $617.00 K(-120.1%) | $845.00 K(-141.9%) | $617.00 K(-370.6%) |
| Sept 2016 | - | -$2.02 M(-284.8%) | -$228.00 K(-112.7%) |
| June 2016 | - | $1.09 M(+56.4%) | $1.79 M(+156.4%) |
| Mar 2016 | - | $698.00 K | $698.00 K |
| Dec 2015 | -$3.07 M(-40.2%) | - | - |
| Dec 2014 | -$5.13 M | - | - |
FAQ
- What is Fulgent Genetics annual free cash flow?
- What is the all time high annual FCF for Fulgent Genetics?
- What is Fulgent Genetics annual FCF year-on-year change?
- What is Fulgent Genetics quarterly free cash flow?
- What is the all time high quarterly FCF for Fulgent Genetics?
- What is Fulgent Genetics quarterly FCF year-on-year change?
- What is Fulgent Genetics TTM free cash flow?
- What is the all time high TTM FCF for Fulgent Genetics?
- What is Fulgent Genetics TTM FCF year-on-year change?
What is Fulgent Genetics annual free cash flow?
The current annual FCF of FLGT is $4.80 M
What is the all time high annual FCF for Fulgent Genetics?
Fulgent Genetics all-time high annual free cash flow is $514.73 M
What is Fulgent Genetics annual FCF year-on-year change?
Over the past year, FLGT annual free cash flow has changed by -$219.95 M (-97.87%)
What is Fulgent Genetics quarterly free cash flow?
The current quarterly FCF of FLGT is -$35.05 M
What is the all time high quarterly FCF for Fulgent Genetics?
Fulgent Genetics all-time high quarterly free cash flow is $221.69 M
What is Fulgent Genetics quarterly FCF year-on-year change?
Over the past year, FLGT quarterly free cash flow has changed by -$40.36 M (-759.13%)
What is Fulgent Genetics TTM free cash flow?
The current TTM FCF of FLGT is -$28.67 M
What is the all time high TTM FCF for Fulgent Genetics?
Fulgent Genetics all-time high TTM free cash flow is $554.12 M
What is Fulgent Genetics TTM FCF year-on-year change?
Over the past year, FLGT TTM free cash flow has changed by -$40.12 M (-350.29%)